The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition.
The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition.
复制标题
DOI:
10.1016/j.neuropharm.2011.03.007
复制
发表时间:
2011-07
影响因子:
4.7
通讯作者:
Leslie, Frances M.
中科院分区:
文献类型:
--
作者:
Lotfipour, Shahrdad;Arnold, Monica M.;Hogenkamp, Derk J.;Gee, Kelvin W.;Belluzzi, James D.;Leslie, Frances M.
Our current study aims to evaluate the mechanisms of tranylcypromine (TCP)-mediated enhancement of nicotine self-administration. We replicated our previous findings which demonstrate that 1-hr pretreatment with TCP (3mg/kg, i.p.) enhances nicotine self-administration (7.5 μg/kg/inj, i.v.) when compared with vehicle-treated rodents. We tested whether TCP-mediated enhancement of nicotine self-administration was due to MAO inhibition or off-target effects by (i) extending the TCP pretreatment time from 1 to 20 hr, and (ii) evaluating the role of the individual TCP stereoisomers in nicotine self-administration studies. While 20-hr and (−)TCP pretreatment induced significant inhibition of MAO (60–90%), animals found nicotine only weakly reinforcing. Furthermore, while both (+) and (±)TCP treatment induced nearly 100% MAO inhibition, (+)TCP pretreated animals took longer to acquire nicotine self-administration compared to (±)TCP pretreated animals. Stable nicotine self-administration in (+)TCP pretreated animals was influenced by nicotinic receptor activation but not nicotine-paired cues. The opposite was found in (±)TCP pretreated animals. Treatment with (−) or (±)TCP increased dopamine and serotonin overflow, while the (+) and (±)TCP treatment enhanced monoamine overflow subsequent to nicotine. Together, our data suggests TCP-enhancement of nicotine self-administration are mediated through mechanisms independent of MAO inhibition, including nicotine-paired cues and monoamine uptake inhibition.
登录
查看更多内容
DOI:
10.1021/jm01241a017
发表时间:
1962-01-01
期刊:
JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY
影响因子:
--
作者:
KAISER, C;ZIRKLE, CL;DAVIS, CS
通讯作者:
DAVIS, CS
影响因子:
10.6
作者:
Diergaarde, Leontien;Pattij, Tommy;De Vries, Taco J.
通讯作者:
De Vries, Taco J.
影响因子:
3.6
作者:
Di Matteo, V;Cacchio, M;Esposito, E
通讯作者:
Esposito, E
影响因子:
5.8
作者:
FUENTES, JA;OLESHANSKY, MA;NEFF, NH
通讯作者:
NEFF, NH
影响因子:
4.1
作者:
Khalil, AA;Steyn, S;Castagnoli, N
通讯作者:
Castagnoli, N